What is Sodium Valproate 300 mg used for?

In the pharmaceutical industry, Sodium Valproate 300 mg is a broad-spectrum Anticonvulsant and Mood Stabilizer. As a pharmacist and manufacturer, I classify this as a “multi-channel” stabilizer. Unlike many other neuro-active drugs that target a single receptor, Sodium Valproate works on several mechanisms simultaneously to “calm” overactive electrical activity in the brain.

Primary Clinical Uses

  • Epilepsy: It is a first-line treatment for various types of seizures, including generalized, partial, absence, and myoclonic seizures.

  • Bipolar Disorder: Used to treat acute manic episodes and as a maintenance therapy to prevent mood swings.

  • Migraine Prophylaxis: Often prescribed to reduce the frequency of chronic migraine headaches in adults when other treatments are insufficient.

  • Neuropathic Pain: Occasionally used off-label for specific types of nerve pain.

Mechanism of Action: The Triple Stabilization

Sodium Valproate increases the “braking” system of the brain while slowing down the “accelerator.”

GABA Enhancement: It increases the concentration of Gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. It does this by inhibiting GABA transaminase (the enzyme that breaks GABA down).

Sodium Channel Blockade: It limits the high-frequency repetitive firing of neurons by blocking voltage-gated sodium channels, preventing the spread of seizure activity.

T-type Calcium Channel Inhibition: In the thalamus, it inhibits specific calcium channels, which is particularly effective for treating absence seizures.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Sodium Valproate 300 mg requires high-level technical precision:

  • The 300 mg “CR” Advantage: As a firm owner, you should know that the Controlled Release (CR) or Chrono formulation is the industry standard for the 300 mg dose. It prevents “peaks and troughs” in the blood, reducing side effects. Marketing this as a “Superior Bioavailability” product on your digital platform is a key USP.

  • Hygroscopic Challenges: Sodium Valproate is highly hygroscopic (it absorbs moisture from the air extremely fast). At our facility, we utilize Alu-Alu blister packaging in a humidity-controlled environment (RH < 30%) to ensure a 36-month shelf life. This is a major selling point for export to Zone IVb regions.

  • The Teratogenicity Warning: As a pharmacist, you must ensure your Product Information Leaflet (PIL) and website clearly display the “Valproate Pregnancy Prevention Program” warnings. Because of the high risk of birth defects, this technical compliance is mandatory for international export to the UK, EU, and Australia.

  • Dossier & Tenders: This is a high-volume essential medicine. We provide full CTD/eCTD Dossiers to help your firm bid for national health tenders and hospital supply contracts globally.

What is lamotrigine 25 mg for?

In the pharmaceutical industry, Lamotrigine 25 mg is a phenyltriazine-class anti-epileptic drug (AED) and mood stabilizer. As a pharmacist, I view the 25 mg strength as the “Gold Standard Initiation Dose.” Because Lamotrigine carries a risk of serious skin reactions (Stevens-Johnson Syndrome) if started too quickly, the 25 mg tablet is used specifically to follow a strict “dose escalation” protocol to ensure patient safety.

Primary Clinical Uses

  • Epilepsy: Used for both partial-onset and generalized seizures, including Lennox-Gastaut syndrome. It works as monotherapy or adjunctive therapy.

  • Bipolar I Disorder: Specifically indicated for maintenance treatment to delay the occurrence of mood episodes (depression, mania, hypomania) in patients treated for acute mood disorders.

  • Off-label uses: Sometimes prescribed for trigeminal neuralgia or certain types of chronic neuropathic pain.

Mechanism of Action: Stabilizing the Neuron

Lamotrigine works by stabilizing the neuronal membrane and modulating the release of excitatory neurotransmitters.

Sodium Channel Blockade: It inhibits voltage-gated sodium channels. By doing so, it suppresses the rapid, repetitive firing of neurons that causes a seizure.

Glutamate Inhibition: By stabilizing the membrane, it inhibits the release of glutamate and aspartate—the brain’s primary “excitatory” chemicals.

Weak Serotonin Inhibition: It also has a weak effect on 5-HT3 receptors, which may contribute to its efficacy as a mood stabilizer in bipolar depression.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamotrigine 25 mg is a high-precision neuro-psychiatric product:

  • The Titration Pack: As a manufacturer, we often produce “Starter Kits” where 25 mg tablets are blistered in a specific sequence (e.g., one daily for 14 days) to prevent patients from accidental overdose during initiation.

  • Dissolution & Dispersibility: We manufacture both standard film-coated tablets and Dispersible/Chewable tablets. Dispersible tablets are highly popular in export markets for pediatric use and for patients with dysphagia (difficulty swallowing).

  • Stability for Global Trade: Lamotrigine is relatively stable but sensitive to moisture. At our WHO-GMP facility, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Lamictal).

Add to cart